we conducted a study of patients in Ghana who had Buruli ulcer, caused by Mycobacterium ulcerans, and found that 23% were coinfected with Mansonella perstans nematodes; 13% of controls also had M. perstans infection. M. perstans co-infection should be considered in the diagnosis and treatment of Buruli ulcer.
During August 2010-December 2012, we conducted a study of patients in Ghana who had Buruli ulcer, caused by Mycobacterium ulcerans, and found that 23% were coinfected with Mansonella perstans nematodes; 13% of controls also had M. perstans infection. M. perstans co-infection should be considered in the diagnosis and treatment of Buruli ulcer. B uruli ulcer, caused by Mycobacterium ulcerans, is a neglected tropical disease common in rural parts of West Africa. Infection with M. ulcerans causes disfiguring skin ulcers, mainly in children. The disease is highly focal, and in Ghana, cases are reported mainly from the humid and tropical southern regions, including Ashanti and Greater Accra (1) . Recent studies suggest that aquatic invertebrates serve as a reservoir for M. ulcerans, although complete transmission pathways remain unknown (2, 3) . Aquatic insects infected with M. ulcerans can establish infection in mice by biting (4), but it is not clear that this is the cause of human infection (5) . In southeastern Australia, evidence has been found linking infected mosquitoes with human cases (6, 7) , but proof of transmission is lacking.
Residents of regions in which Buruli ulcer is endemic are frequently exposed to parasitic infections such as filariasis. In Ghana, lymphatic filariasis caused by Wuchereria bancrofti nematodes is found in several regions to which Buruli ulcer is endemic, such as the Upper Denkyira District in the central region of Ghana, but its prevalence is unknown (8) . The filarial nematode Mansonella perstans is endemic to countries in central and western Africa; its distribution overlaps that of other filarial nematodes W. bancrofti, Loa loa, and Onchocerca volvulus (9) . Infective M. perstans larvae are transmitted through the bite of Culicoides midges (Diptera: Ceratopogonidae); the larvae develop over the course of months into adult worms that reside in serous cavities, particularly in the abdomen. M. perstans infection is not associated with a specific set of clinical signs and symptoms, but those attributed to this infection include acute swelling in the forearms, hands, and face that recedes in a few days and often recurs; itching with or without rash; arthralgia; and eosinophilia (9) .
During an investigation into the immunopathogenesis of Buruli ulcer, we observed M. perstans nematodes in preparations of peripheral blood mononuclear cells from a patient. This finding led us to consider whether this organism was involved in the transmission or pathogenesis of M. ulcerans disease or if the finding was incidental. We then conducted a small case-control study to investigate the frequency of M. perstans co-infection in patients with M. ulcerans disease and the effect of this co-infection, if any, on patient response to antimicrobial drug therapy.
The Study
During August 2010-December 2012, we recruited all patients who had clinically suspected M. ulcerans infection and had attended a clinic in the Buruli ulcer-endemic Asante Akim North District in Ghana. Age-and sex-matched household contacts of patients were also asked to participate; all study participants were >5 years of age. The study protocol was approved by the ethics review committee of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology (CHRPE/91/10).
Whole blood samples were taken at baseline, at week 6, and at week 12 from 66 patients in whom the diagnosis of Buruli ulcer disease had been confirmed by PCR for the IS2404 repeat sequence specific for M. ulcerans (8) ; samples were also obtained from 20 household contacts at the same intervals. The samples were heparinized, and peripheral blood mononuclear cells were separated from 10-mL samples. Filarial infection was confirmed on a blood film stained with Giemsa and Delafield hematoxylin and examined for microfilariae at ×10 and ×40 magnification (the Knott technique; 10). M. perstans nematodes were distinguished from L. loa and W. bancrofti nematodes by their small size and the absence of a sheath (Figure 1 ).
Patients in whom M. ulcerans infection was found were treated with 10 mg/kg oral rifampin and 15 mg/kg intramuscular streptomycin, administered daily at village health posts under direct observation for 8 weeks (RS8 treatment). The patients were followed up every 2 weeks in the clinic and monitored for complete healing or recurrence of skin lesions. We compared the proportion of household controls versus the proportion of Buruli ulcer patients infected with M. perstans nematodes and the time to complete healing of M. ulcerans lesions in co-infected versus monoinfected patients. Categorical variables such as sex, clinical form of M. ulcerans lesion, and category of M. ulcerans lesion were compared by using the Fisher exact test, and cumulative healing was compared by using the log-rank test.
We found all forms of M. ulcerans disease among the group of patients; proportions of each type and category are shown in the All 66 patients completed RS8 treatment, but 9 were lost to follow-up during the 12-month follow-up period. Buruli ulcer lesions healed completely in 14 co-infected patients by 58 weeks (median 20 weeks, 95% CI 14.6-30.2) and in 43 monoinfected patients by 50 weeks (median 21 weeks, 95% CI 16.7-25.5). We found no difference in cumulative time to healing for co-infected versus monoinfected patients (p>0.05 by log-rank test) ( Figure  2 ). Buruli ulcer patients who had M. perstans nematodes co-infection were treated with doxycycline (200 mg) and ivermectin (150 μg/kg) daily for 6 weeks, starting during the second to fourth week of RS8 treatment. Viable microfilariae were still visible in peripheral blood mononuclear cell cultures from all co-infected patients after ivermectin and doxycycline treatment, but pruritus subsided in the 3 patients who had reported it.
Conclusions
We found co-infection with M. perstans in 23% of Buruli ulcer patients in a disease-endemic district in Ghana, but this prevalence was not significantly difference from prevalence among household contacts who served as controls (13%). As with Buruli ulcer, M. perstans filariasis is predominantly found in rural populations and infection begins in childhood; the highest infection rates are found in children 10-14 years of age (11) , similar to those for children at highest risk for M. ulcerans infection. M. perstans infection occurs in Ghana and was seen in the Volta region of Ghana around Hohoe during the 1990s, but its prevalence is unknown (12) , and no information is available about the average number of worms per infection. In Uganda, prevalence of M. perstans infection has been found to range from 0.4% to 50% (13) .
M. perstans nematodes are transmitted by the bites of Culicoides midges, but it is not known whether M. perstans-infected midges can be co-infected with M. ulcerans. In a guinea pig model, skin penetration was shown to be a requirement for establishment of M. ulcerans disease (14) , and it has been postulated that mosquito bites cause M. ulcerans disease in Australia (6) . These organisms might share a common route of transmission, but our findings in this small study do not support this concept.
Our findings suggest that M. perstans nematodes are common in rural Ghana and coincidentally infect patients with M. ulcerans disease, necessitating the consideration of these organisms in the management plan of Buruli ulcer patients. Although often asymptomatic, M. perstans infection may cause eosinophilia, subcutaneous swellings, aches, pains, and skin rashes in a considerable proportion of patients (9) . Because filarial nematodes are known to polarize the host immune responses from T-helper type 1 cells needed for protection against mycobacterial infections, toward humoral and T helper type-2 mediated immunity, we plan to undertake a study to investigate this interaction. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 20, No. 6, June 2014 
